COVID-19 booster update
Oct. 2022Important Notices
The FDA authorized bivalent formulations of the Moderna and Pfizer-BioNTech COVID-19 vaccines for use as a single booster dose at least two months after completing primary or booster vaccination. Anyone age 12 and older who has gotten the primary vaccination series with or without an additional booster is eligible.
- The Moderna COVID-19 Vaccine, Bivalent, is authorized for use as single booster dose in individuals 18 years old and older.
- The Pfizer-BioNTech COVID-19 Vaccine, Bivalent, is authorized for use as a single booster dose in individuals 12 years old and older.
Read more about COVID-19 Bivalent vaccine boosters.
Additionally, you may also visit the CDC to learn how to find a COVID-19 vaccine. Primary vaccinations and boosters for COVID-19 can be given the same day as the annual flu shot, also now available at providers and pharmacies across the Commonwealth.
For the most recent COVID-19 policy and billing updates from UPMC Health Plan, please see these resources:
Recent Announcements
Voluntary nationwide recall: Famotidine (Fresenius – November)
Fresenius Kabi USA, LLC is recalling three lots (6133156, 6133194, and 6133388) of Famotidine Injection, USP, 20 mg per 2 mL. Famotidine is used to treat excessive secretion of stomach acid or stomach ulcers.Nov. 2025Pharmacy Updates
Medicaid provider update: High-cost Medicaid drug billing
Billing requirements for Medicaid-covered drugsNov. 2025Important Notices
Training Webinar: Conversio Health COPD Management Program
Please join us for a live training webinar for primary care providers and pulmonologists by UPMC Health Plan that will provide an overview of a comprehensive COPD management program from Conversio Health.Nov. 2025Education/Webinars